Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide. It is strongly associated with obesity, type 2 diabetes (T2DM), and other …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed
nonalcoholic fatty-liver disease, is an important and rising health issue with a link with …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most frequent cause of liver
disease worldwide, comprising a plethora of conditions, ranging from steatosis to end‐stage …

Individuals with nonalcoholic fatty liver disease (NAFLD) are characterized by increased
cardiovascular risk. Endothelial dysfunction, a mechanism implicated in those processes …

Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease globally
and in India. The already high burden of NAFLD in India is expected to further increase in …

Introduction Nonalcoholic fatty liver disease (NAFLD) frequently coexists with type 2
diabetes mellitus (T2DM) and synergistically contributes to the development of …

Background Endothelial dysfunction is associated with elevated cardiovascular risk in
patients with end-stage renal disease (ESRD). Kidney transplantation has demonstrated …

Obesity, non-alcoholic fatty liver disease (NAFLD), and atherosclerotic cardiovascular
diseases are common and growing public health concerns. Previous epidemiological …

NAFLD is currently considered the most common liver disease worldwide and mounting
data support its strong link with atherosclerotic cardiovascular disease (ASCVD). This …

Abstract Background & Aims Cardiovascular disease (CVD) is the main cause of mortality
among non‐alcoholic fatty liver disease (NAFLD) patients. The aim was to explore the level …